Firstsource Solutions Ltd - 532809 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Schedule of Analyst/ Institutional Investor Meetings with the Key Managerial Personnel (KMP) of the Company that took place during the month of September 2021. This is for your information and record. Firstsource Solutions Ltd - 532809 - Closure of Trading Window
In reference to the clarification regarding trading restriction period issued by National Stock Exchange of India Limited vide its Letter Ref No: NSE/CML/2019/11 dated 2nd April 2019 and BSE Limited vide its Letter Ref. No: LIST/COMP/01/2019-20 dated2nd April 2019 and in view of Prohibition of Insider Trading, Regulations 2015, the 'Trading Window' for Trading in the securities of the Company will remain closed from Friday, 1st October 2021 till conclusion of the 48 hours post the Board Meeting for the purpose of declaration of audited financial results for the quarter ended 30th September 2021, the date of which shall be intimated in due course. You are requested to take the above on record. FIRSTSOURCE SOLUTIONS LTD. - 532809 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that 45,000 shares have been allotted as per Firstsource Solutions Employee Stock Option Scheme - 2003 (ESOS 2003) on 28th September 2021, pursuant to the exercise of the Stock Options granted under the Company's ESOS 2003. We request you to kindly take the same on your record. FIRSTSOURCE SOLUTIONS LTD. - 532809 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that 45,814 shares have been allotted as per Firstsource Solutions Employee Stock Option Scheme - 2003 (ESOS 2003) on 24th September 2021, pursuant to the exercise of the Stock Options granted under the Company's ESOS 2003. We request you to kindly take the same on your record. Firstsource Solutions Ltd - 532809 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that 13,375 shares have been allotted as per Firstsource Solutions Limited Employee Stock Option Plan 2019 (ESOP 2019 Plan) on 22nd September 2021, pursuant to the exercise of the Stock Options granted under the Company's ESOP 2019 Plan. The exercise price of the shares as per the ESOP 2019 Plan is the face value of the shares of the Company i.e. Rs. 10/- per share. We request you to kindly take the same on your record. Firstsource Solutions Ltd - 532809 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached herewith the press release titled 'Firstsource awarded IIP ''We invest in people'' Gold accreditation for the second time in a row' which will be disseminated shortly. The Press release is self-explanatory. We request you to take the above on record. FIRSTSOURCE SOLUTIONS LTD. - 532809 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find attached herewith the press release titled 'Firstsource Launches Strategic Transition to Cloud for all Healthcare Solutions, Accelerating Innovation, Access, Security and Flexibility for Clients' which will be disseminated shortly. The Press release is self-explanatory. We request you to take the above on record. FIRSTSOURCE SOLUTIONS LTD. - 532809 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that 52,625 shares have been allotted as per Firstsource Solutions Limited Employee Stock Option Plan 2019 (ESOP 2019 Plan) on 7th September 2021, pursuant to the exercise of the Stock Options granted under the Company's ESOP 2019 Plan. The exercise price of the shares as per the ESOP 2019 Plan is the face value of the shares of the Company i.e. Rs. 10/- per share. We request you to kindly take the same on your record. FIRSTSOURCE SOLUTIONS LTD. - 532809 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform you that the Company has allotted 146,877 Equity shares of Rs. 10/- each bearing distinctive numbers 696,843,950 to 696,990,826 on 7th September 2021 under Employee Stock Option Scheme 2003 of the Company. Consequent to the said allotment, the paid up capital of the Company has increased to Rs. 6,969,908,260/- consisting of 696,990,826 Equity shares of Rs. 10/- each. We request you to take the above intimation on record, which has been made to you pursuant to Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
No signs of unnatural death in Sidharth Shukla's case: Police
The autopsy report of actor Sidharth Shukla, who died at the age of 40, does not mention the exact cause of death, police sources said on Friday. The cause of the death will be known after reports of chemical analysis of the viscera and histopathology tests, a police official said. "On the face of it, there were no signs of unnatural death (as per the autopsy report)," the official said, referring to reports that a heart attack led to Shukla's demise. There were no external injuries on the actor's body, another police official said. The actor's viscera has been sent to the Kalina Forensic Science Laboratory (FSL) in Mumbai and some organs were sent to the pathology laboratory of a medical college for examination, a source at the civic-run R N Cooper Hospital said. A forensic expert from the hospital said they sent the viscera to the FSL to rule out the possibility of foul play. "The FSL will investigate for the presence of toxicity in the organs and other details," he said, addi